Xiaoqing Chen Selected Research

Cell-Free Nucleic Acids

1/2022	A pilot study of the use of dynamic analysis of cell-free DNA from aqueous humor and vitreous fluid for the diagnosis and treatment monitoring of vitreoretinal lymphomas.
11/2018	Valency-Controlled Framework Nucleic Acid Signal Amplifiers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaoqing Chen Research Topics

Disease

36	Neoplasms (Cancer) 06/2022 - 02/2002
35	Breast Neoplasms (Breast Cancer) 01/2022 - 05/2002
19	Inflammation (Inflammations) 05/2022 - 12/2008
14	Infections 10/2022 - 07/2012
12	Ovarian Neoplasms (Ovarian Cancer) 01/2017 - 07/2002
11	Uveitis 05/2022 - 10/2015
7	Atherosclerosis 07/2016 - 08/2011
5	Fibrosis (Cirrhosis) 01/2021 - 01/2014
5	Carcinogenesis 06/2019 - 03/2008
4	Herpes Simplex 01/2020 - 07/2012
4	Systemic Lupus Erythematosus (Libman-Sacks Disease) 06/2018 - 01/2008
4	Atrial Fibrillation 01/2018 - 01/2014
4	Ovarian Epithelial Carcinoma 02/2016 - 12/2008
3	Non-alcoholic Fatty Liver Disease 08/2022 - 02/2018
3	Neoplasm Metastasis (Metastasis) 06/2022 - 01/2022
3	Birth Weight (Birth Weights) 02/2022 - 01/2020
3	Graves Ophthalmopathy 02/2021 - 01/2017
3	Autoimmune Diseases (Autoimmune Disease) 02/2021 - 01/2008
3	Allergic Conjunctivitis (Giant Papillary Conjunctivitis) 09/2020 - 10/2014
3	Spinal Cord Diseases 05/2019 - 07/2011
3	Pathologic Constriction (Stenosis) 01/2019 - 03/2011
3	Lung Injury 08/2015 - 01/2013
3	Ataxia Telangiectasia (Louis Bar Syndrome) 05/2015 - 02/2002
2	Dysbiosis 08/2022 - 07/2021
2	Retinal Vasculitis 05/2022 - 04/2021
2	Critical Illness (Critically Ill) 02/2022 - 09/2021
2	Ulcerative Colitis 01/2022 - 02/2021
2	Cardiomegaly (Heart Hypertrophy) 01/2022 - 01/2021
2	Hypertrophy 01/2022 - 01/2018
2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 11/2015
2	Heart Failure 10/2021 - 01/2019
2	Fever (Fevers) 09/2021 - 01/2021
2	Hyperoxia 01/2021 - 08/2019
2	Sepsis (Septicemia) 01/2021 - 01/2013
2	Carcinoma (Carcinomatosis) 01/2021 - 09/2016
2	Acute Lung Injury 01/2021 - 02/2014
2	Body Weight (Weight, Body) 05/2020 - 01/2020
2	Corneal Neovascularization 01/2020 - 01/2013
2	Parkinson Disease (Parkinson's Disease) 11/2019 - 06/2013
2	Cytokine Release Syndrome 03/2019 - 01/2014
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 05/2013
2	Intervertebral Disc Displacement (Herniated Disc) 01/2019 - 12/2018
2	Wounds and Injuries (Trauma) 01/2018 - 10/2013
2	Pneumonia (Pneumonitis) 08/2015 - 01/2013
2	Prostatic Neoplasms (Prostate Cancer) 08/2014 - 07/2002
2	Splenomegaly 07/2014 - 07/2012

Drug/Important Bio-Agent (IBA)

19	Proteins (Proteins, Gene)FDA Link 10/2022 - 07/2005
13	Estrogen ReceptorsIBA 01/2022 - 09/2009
11	CytokinesIBA 11/2021 - 01/2013
9	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2008
7	DNA (Deoxyribonucleic Acid)IBA 06/2022 - 05/2010
7	MicroRNAs (MicroRNA)IBA 02/2022 - 02/2016
7	Progesterone Receptors (Progesterone Receptor)IBA 01/2022 - 05/2002
6	Messenger RNA (mRNA)IBA 01/2022 - 09/2002
6	Biological ProductsIBA 01/2021 - 08/2011
5	Anti-Bacterial Agents (Antibiotics)IBA 08/2022 - 01/2013
5	Hormones (Hormone)IBA 05/2022 - 07/2002
5	Apolipoproteins E (ApoE)IBA 07/2016 - 07/2012
4	Retinaldehyde (Retinal)IBA 05/2022 - 12/2019
4	human ERBB2 proteinIBA 01/2022 - 12/2011
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2021 - 01/2014
4	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2014
4	Pharmaceutical PreparationsIBA 12/2020 - 01/2018
4	Antiviral Agents (Antivirals)IBA 07/2015 - 05/2013
3	EnzymesIBA 01/2022 - 07/2005
3	ChemokinesIBA 01/2022 - 01/2008
3	Toll-Like Receptor 4IBA 01/2020 - 01/2013
3	Interleukin-4 (Interleukin 4)IBA 11/2018 - 01/2014
3	Transcription Factors (Transcription Factor)IBA 01/2018 - 09/2009
3	AntioxidantsIBA 11/2015 - 12/2007
3	Doxycycline (Periostat)FDA LinkGeneric 10/2015 - 01/2013
3	ApolipoproteinsIBA 08/2015 - 07/2012
3	Protein Kinases (Protein Kinase)IBA 07/2011 - 02/2002
2	Adenosine Triphosphate (ATP)IBA 06/2022 - 07/2014
2	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2022 - 08/2018
2	Cell-Free Nucleic AcidsIBA 01/2022 - 11/2018
2	Streptozocin (Streptozotocin)FDA Link 01/2022 - 05/2020
2	Long Noncoding RNAIBA 12/2021 - 11/2021
2	LigandsIBA 10/2021 - 01/2021
2	Interleukin-17 (Interleukin 17)IBA 02/2021 - 11/2018
2	Transforming Growth Factor-beta Type I ReceptorIBA 11/2020 - 01/2020
2	Peptides (Polypeptides)IBA 10/2020 - 01/2018
2	Caspase 8 (Caspase-8)IBA 01/2020 - 01/2018
2	Viral DNAIBA 01/2020 - 02/2016
2	Surface-Active Agents (Surfactants)IBA 01/2020 - 08/2019
2	SaponinsIBA 10/2019 - 02/2018
2	InterferonsIBA 03/2019 - 01/2008
2	TNF Receptor-Associated Factor 6 (TRAF6)IBA 01/2017 - 01/2014
2	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 01/2017 - 10/2016
2	Rituximab (Mabthera)FDA Link 01/2017 - 07/2011
2	Eplerenone (Inspra)FDA LinkGeneric 01/2017 - 10/2016
2	Connective Tissue Growth FactorIBA 01/2017 - 10/2016
2	pristane (pristan)IBA 07/2016 - 01/2014
2	Toll-Like Receptors (Toll-Like Receptor)IBA 07/2016 - 08/2015
2	CholesterolIBA 08/2015 - 07/2014
2	FlavonoidsIBA 01/2015 - 01/2014
2	Immunoglobulin G (IgG)IBA 07/2014 - 07/2012

Therapy/Procedure

14	Therapeutics 01/2022 - 01/2015
4	Diskectomy (Discectomy) 01/2019 - 01/2016
2	Laminoplasty 05/2019 - 01/2018